##
|Contents|||Page|
|---|---|---|---|
|Trustees'
report||||
|Report ofthe independent||auditor||
|Statements
of financial|activities|||
|Balance sheets|||13|
|Consolidated
statement|of|cash flows|14|
|Notes to the financial statements|||15|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||Nates||Unrestricted|Restricted|Total funds|1'otal funds|
|---|---|---|---|---|---|---|
||||funds 2020|funds 2020|2020|2019|
||||6|6|6|6|
|Income|||||||
|Charitable
activities:
subscriptions
industry
partnership
Courses and meetings||2|253,177
232,375
239,134|8,400|253,177
232,375
247,534|257,181
255,142
1,341,138|
|Other trading
activities:
Commercial
trading operations|||385,535||385,535|424,105|
|Investment
income||||||76|
|Otherincame|||||4|2,328|
|Total income|||1,110,232|8,400|1,118,632|2,279,970|
|Expenditure
on|||||||
|Raising funds:
Raising funds||4|234,060||234,060|211,738|
|Charitable
activities:
Publications
and apps
Courses and meetings
Grants||5
2
7|148,635
681,749
37,996|8,400|148,635
690,149
37,996|213,496
1,753,847
36,770|
|Total expenditure|||1,102,440|8,400|1,110,840|2,215,851|
|Net movements
in funds||6|7,792||7,792|64,119|
|Funds brought
forward|||1,294,475||1,294,475|1,230,356|
|Funds carried forward|||61,302,267||61,302,267|61,294,475|
##
||Notes||Unrestricted|Restricted|Total funds|Total funds|
|---|---|---|---|---|---|---|
||||funds 2020|funds 2020|2020|2019|
||||6|6|6||
|Income|||||||
|Charitable
activities:|||||||
|subscriptions|||253,177||253,177|257,181|
|Industry
partnerships|||97,821||97,821|255,142|
|Courses and meetings||2|42,620|8,400|51,020|276,183|
|Investment
income||3|255,589||255,589|208,598|
|Otherincome||||||2,328|
|Total income|||649,211|8,400|657,611|999,432|
|Expenditure
on|||||||
|Raising funds:|||||||
|Raising funds||4|49,967||49,967|52,023|
|Charitable
activities:|||||||
|Publications||5|122,493||122,493|181,646|
|Courses and meetings||2|149,617|8,400|158,017|303,395|
|Grants||7|237,950||237,950|451,363|
|Total resources expended|||560,027|8,400|568,427|988,427|
|Net movements
in funds||6|89,184||89,184|11,005|
|Funds brought
forward|||1,030,435||1,030,435|1,019,430|
|Funds carried forward|||61,219,619|6-|61,119,619|61,030,435|
##
||European|Society For Vascular Surgery|Society For Vascular Surgery|Society For Vascular Surgery|||
|---|---|---|---|---|---|---|
||Balance|sheets as at 31December 2020|||||
|Company
number:|4524120|Notes|2020|2020|2019|2019|
||||Group|Charity|Group|Chadity|
||||C|C|C|C|
|Fixed assets|||||||
|Tangible assets||10|5,517||9,293||
|Investments||11|||||
||||5,517|2|9,293||
|Current assets|||||||
|Debtors - due within|one year|12|309,974|191,195|434,680|185,633|
|Cash at bank and in|hand||1,393,983|1,231,280|1,319,597|1,240,111|
||||1,703,957|1,422,475|1,754,277|1,425,744|
|Creditors: amounts|falling due within one year|13|(407,207)|(302,858)|(469,095)|(395,311)|
|Net current assets|||1,296,750|1,119,617|1,285,182|1,030,433|
|Net assets|||C1,302,267|C1,119,619|C1,294,475|C1,030,435|
|Unrestricted
funds|||||||
|General funds|||1,302,267|1,119,619|1,294,475|1,030,435|
|Restricted funds|||||||
|Totalfunds|||C1302 267|C1119619|C1r294r475|C1030435|
##
||||2020|2019|
|---|---|---|---|---|
||||6|6|
|Net cash inflow from operating
activities (below)|||74,379|531,685|
|Cosh flows from investing
activities|||||
|Investment
income received||||76|
|Investment
eliminated
on first consolidation||||1|
|Purchase of furniture
and equipment||||(14,621)|
|Net cash flow from investing
activities||||(14,544)|
|Cosh flows from financing
activities|||||
|Increase
in cash and cash equivalents|in the year||74,386|517,141|
|Cash and cash equivalents
brought
forward|||1,319,597|802,456|
|Cash and cash equivalents
carried forward|||1,393,983|1,319,597|
|Reconciliation
ofsurplus to net cash inflow from operating||activities|||
|Surplus for the year|||7,792|64,119|
|Adjustments
to reconcile surplus for the year to net cosh flow from operating|||activities||
|Decrease
in debtors|||124,706|335,849|
|(Decrease)/increase
in creditors|||(61,888)|126,465|
|Depreciation
oftangible
fixed assets|||3,776|5,328|
|Investment
income receivable|||(7)|(76)|
|Net cash inflow from operating
activities|||74,379|531,685|
|Analysis
of changes
in net debt|||||
|Cash at 1January|||1,319,597|802,456|
|Cash flows|||74,386|517,141|
|Cash at 31December|||1,393,983|1,319,597|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|2|Courses and conferences|Courses and conferences||||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||||2020|2019|
||||||||||«|
||Group|||||||||
||Income —unrestricted|||||||||
||Annual
Conference,|Spring|Meeting||8 Masterclass|||196,514|1,219,176|
||Courses|||||||42,620|81,858|
|||||||||239,134|1,301,033|
||Restricted fund income —Annual|||Conference||Grants||8,400|40,104|
||Total income|||||||247,534|1,341,138|
||Expenditure
-unrestricted|||||||||
||Annual
Conference,|Spring|Meeting||8 Masterclass|||272,476|1,266,377|
||Courses|||||||47,886|61,313|
||Webinars
8& e-library|||||||29,532|29,164|
||Support
Costs (note|9)||||||331,855|356,889|
|||||||||681,749|1,713,743|
||Restricted fund expenditure||—Annual||Conference||Grants|8,400|40,104|
||Total expenditure|||||||690,149|1,753,847|
||Net cost ofcourses and conferences|||||||«442,615|«412,709|
||Charity|||||||||
||Income
—unrestricted|||||||||
||Courses|||||||42,620|81,858|
||Annual
Conference,|Spring|Meeting||gr Masterclass||||154,221|
|||||||||42,620|236,079|
||Restricted fund income —Annual|||Conference||Grants||8,400|40,104|
||Tatal income|||||||51,020|276,183|
||Expenditure
—unrestricted|||||||||
||Annual
Canference,|Spring|Meeting||8 Masterclass||||54,140|
||Courses|||||||47,886|61,313|
||Webinars
gr e-library|||||||29,532|29,164|
||Support Casts (note|9)||||||72,199|118,674|
|||||||||149,617|263,291|
||Restncted fund expenditure||—Annual||Conference||Grants|8,400|40,104|
||Total expenditure|||||||158,017|303,395|
||Net cast ofcourses and conferences|||||||«106,997|«27,212|
##
|3|Investment
income|Investment
income|Investment
income||||||
|---|---|---|---|---|---|---|---|---|
||||||||2020|2019|
||||||||6||
||Group||||||||
||Income from|listed|investments|||and bank interest||876|
||Charity||||||||
||ESVS Conferences||Limited||—Gift|Aid Donation|255,589|208,522|
||Income from|listed|investments|||and bank interest||76|
||||||||6255,589|6208,598|
|4|Raising funds||||||||
||||||||2020|2019|
|||||||||6|
||Group||||||||
||Membership|management|||services||4,000|4,000|
||Support costs (note|||9)|||39,983|35,444|
||Marketing
gr|Business Development|||||17,268|21,279|
||Costs of generating|||income from||subsidiaries|172,809|151,015|
||||||||6234,060|6211,738|
||Charity||||||||
||Membership|management|||services||24,000|24,000|
||Marketing 5|Business Development|||||17,268|21,280|
||Support costs (note|||9)|||8,699|6,743|
||||||||649,967|452,023|
|5|Publications|—group||and charity|||||
||||||||2020|2019|
||||||||6|6|
||Expenditure
-charity||||||||
||Journal subscription|||costs|||108,085|110,977|
||Guidelines||||||10,003|45,083|
||Vascunet||||||56|18,843|
||Support costs (note|||9)|||4,349|6,743|
||Total expenditure
-||charity||||4122,493|0181,646|
||Expenditure —group||||||||
||Additional
support||costs (note 9)||||15,642|14,350|
||Guideline
App||||||10,500|17,500|
||Tata
I expenditure
—group||||||0148,635|6213,496|
##
|6|Net movement
in|funds|funds|||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||||2020|2019|
||||||||||6|
||The net movement|in|funds for the year is stated||||after charging:|||
||Auditors'
remuneration|||—for services|as auditors-||group and charity|10,893|10,066|
||Depreciation —group||only|||||3,776|5,328|
|7|Grants|||||||||
|||||||||2020|2019|
|||||||||6|6|
||Group and charity|||||||||
||Educational
travel|grants and Annual|||Meeting|Grants||30,000|28,333|
||Allocated support|costs||(note 9)||||7,996|8,437|
||Total for Group|||||||637,996|636,770|
||Charity|||||||||
||Subvention
to European|||Vascular Surgery Trading|||Limited|206,210|420,333|
||Reduction
in allocated||support costs||compared|with Group (note 9)||(6,256)|(5,740)|
||Total for Charity|||||||6237,950|6451,363|
||Grants were payable to|||ten (2019:sixteen) individuals.||||||
|8|Employee costs|||||||||
|||||||||2020|2019|
||Group
Wages, salaries and honoraria|||||||329,008|291,481|
||Social security costs|||||||64,021|43,659|
||Pension contributions|||||||14,276|15,931|
||Tota
I|||||||&407,305|6351,071|
||Charity|||||||||
||Wages, salaries and honoraria|||||||67,875|69,000|
##
##
|Support casts|||
|---|---|---|
||2020|2019|
||6|6|
|Charity|||
|Travel costs|18,770|63,655|
|Office costs|4,272|14,235|
|Employee
costs|18,875|21,000|
|Audit and accountancy|30,893|30,066|
|Bank charges, legal fees and insurance|5,457|10,243|
|Exchange rate differences|8,720|(4,342)|
|Total for Charity|686,987|0134,857|
|Additional
Group support costs|||
|Office costs|23,692|45,178|
|Employee
costs|278,292|227,390|
|Audit and accountancy|5,894|6,885|
|Bank charges,
legal fees and insurance|1,184||
|Corporation
tax (France)||2,225|
|Depreciation|3,776|5,328|
|Total for Group|6399,825|6421,863|
|Support costs have been|apportioned|against the activities ofthe charity|in accordance
with|estimated|management|
|---|---|---|---|---|---|
|time spent on each activity as shown||below;||||
||||2020||2019|
||||||6|
|Group||||||
|Raising funds (note 4)|||39,983||35,444|
|Publications
(note 5)|||19,991||21,093|
|Grants (note 7)|||7,996||8,437|
|Courses and conferences|(note 2)||331,855||356,889|
||||6399,825||&421,863|
|Chority||||||
|Raising funds (note 4)|||8,699||6,743|
|Publications
(note 5)|||4,349||6,743|
|Grants (note 7)|||1,740||2,697|
|Courses and conferences|(note 2)||72,199||118,674|
||||686,987||0134,857|
##
|10|Tangible fixed assets —group|Tangible fixed assets —group||
|---|---|---|---|
||||Office equipment|
||||8|
||Cost|||
||At 1January|and 31December 2020|14,621|
||Depreciation
At 1January
Provided
in|2020
year|5,328
3,776|
||At 31December 2020||9,104|
||Illet Book Value|||
||At 31December 2020||45,517|
||At 31December 2019||69,293|
|11|Investments|- Charity||
||||investment
in|
||||Subsidiaries|
||||8|
||Cost|||
||At 1January|and 31December 2020||
##
|Debtors|||||
|---|---|---|---|---|
||||2020|2019|
|||||g|
|Group
Other debtors|||6309,974|6434,680|
|Charity
Other debtors|||70,936|23,351|
|Due from subsidiary|companies|(note 17)|120,259|162,282|
||||C191,195|6185,633|
##
|13|Creditors: amounts|Creditors: amounts|falling due|falling due|within one year|||
|---|---|---|---|---|---|---|---|
|||||||2020|2019|
|||||||6|g|
||Group|||||||
||Trade creditors|||||15,179|3,524|
||Corporation
tax||||||1,899|
||Other taxation
and||social security|||39,830|34,779|
||Accruals|and deferred||income||352,198|428,893|
|||||||6407,207|6469,095|
||Charity|||||||
||Trade creditors|||||10,592||
||Accruals|and deferred||income||185,389|312,764|
||Amounts|owed to|subsidiaries|||106,877|82,547|
|||||||6302,858|6395,311|
|14|Deferred|income —group and|||charity|||
|||||||2020|2019|
|||||||6|6|
||Balance|at 1January||||47,965|20,972|
||Amounts|released|to|incoming|resources|(47,965)|(20,972)|
||Amounts|deferred|in|the year||15,963|47,965|
||Balance|at 31December||||615,963|647,965|
##
##
##
##
##
##
##
|||||2020|2019|
|---|---|---|---|---|---|
|||||8|6|
|Profit and loss account||||||
|Turnover||||385,542|424,104|
|Administrative|expenses|||(183,309)|(168,515)|
|Gift aid payment
to European|||Society for Vascular Surgery|(255,589)|(208,522)|
|(Loss)/profit|reported|by subsidiary||C(53,346)|447,067|
|trading
results
is shown
be
the Registrar of Companies.|low.
The company's
accaunts
are exempt f|rom statutory
audit and have|been filed wi|
|---|---|---|---|
|||2020|2019|
|||6|6|
|Profit and loss account||||
|Turnover||337,068|1,064,955|
|Subvention
from European|Society for Vascular Surgery|206,210|420,333|
|Administrative
expenses||(543,278)|(1,485,288)|
|Prafit retained
in subsidiary||||
##
##
##
|Net income from trading|activities of subsidiaries|activities of subsidiaries|(continued]|(continued]|||
|---|---|---|---|---|---|---|
|SASU ESI/5 France (continued)|||||2020|2019|
||||||6|6|
|Profit and loss account|||||||
|Turnover|||||290,000|368,847|
|Administrative
expenses|||||(312,036)|(360,576)|
|Corporation
Tax||||||(2,225)|
|Dividend
paid to European||Vascular Surgery Trading||Limited|(6,000)||
|(Loss)/profit
retained
in|subsidiary||||E(28,036)|66,046|
||||Notes|Unrestricted|Restricted|Total funds|
|---|---|---|---|---|---|---|
|||||funds 2019|funds 2019|2019|
|Income||||6|6|6|
|Charitable
activities:|||||||
|Subscriptions||||257,181||257,181|
|Industry
partnership||||255,142||255,142|
|Caurses
and|meetings|||1,301,034|40,104|1,341,138|
|Other trading
activities:|||||||
|Commercial|trading operations|||424,105||424,105|
|Investment
income||||76||76|
|Other income||||2,328||2,328|
|Total income||||2,239,866|40,104|2,279,970|
|Expenditure
on|||||||
|Raising funds:|||||||
|Raising funds||||211,738||211,738|
|Charitable
octivities:|||||||
|Publications|and apps|||213,496||213,496|
|Courses and|meetings|||1,713,743|40,104|1,753,847|
|Grants||||36,770||36,770|
|Total expenditure||||2,175,747|40,104|2,215,851|
|Net income before gains on investment|||assets|64,119||64,119|
|Net (losses)/gains|on investment|assets|||||
|Net movements|in funds|||64,119||64,119|
|Funds brought
forward||||1,730,356||1,230,356|
|Funds carried forward||||61,294,475|6-|61,294,475|
##
|?0|Comparative
information|(continuedi|(continuedi|- Charity statement affinancial activities far|- Charity statement affinancial activities far|the year ta 32|December 2019|
|---|---|---|---|---|---|---|---|
|||||Nates|Unrestricted|Restricted|Total funds|
||||||funds 2019|funds 2019|2019|
||||||6|6|8|
||Income|||||||
||Charitable
activities:|||||||
||Subscriptions||||257,181||257,181|
||Industry
partnerships
Courses and meetings||||255,142
236,079|40,104|255,142
276,183|
||Investment
income||||208,598||208,598|
||Other income||||2,328||2,328|
||Total incame||||959,328|40,104|999,432|
||Expenditure
on|||||||
||Raising funds:
Raising funds||||52,023||52,023|
||Charitable
activities:|||||||
||Publications||||181,646||181,646|
||Courses and meetings||||263,291|40,104|303,395|
||Grants||||451,363||451,363|
||Total resources expended||||948p323|40,104|988,427|
||Net income before gains|on investment||assets|11,005||11,005|
||Net (lossesi/gains
on investment||assets|||||
||Net movements
in funds||||11,005||11,005|
||Funds braught
forward||||1,019,430||1,019,430|
||Funds carried forward||||61,030,435|6-|81,030,435|
##